Similar to the therapeutic approach of GLP-1RA in T1D demonstrated in multiple clinical trials (169171), microvascular protection might also be achieved with SGLT-2 inhibitors, with some trials aiming to minimize the risk of ketosis (172), such as by using glucagon (GCG) inhibitors (173176), as research has shown specific benefits that could be derived from this, independent of the different pathophysiology of microvascular complications in T2DM (177)
While not a medical term, this is a real and increasingly common outcome of Ozempic use
When your immune system is healthy, you can put more effort into fitness and daily performance
It protects cells, detoxifies the liver, and supports the immune system
References Hsieh MJ, Liu HT, Wang CN, et al
M., Kwon, E